Financial Ratios | Morepen Laboratories Ltd. | R Wadiwala Securities Pvt Ltd

MOREPEN LABORATORIES LTD.

NSE : MOREPENLABBSE : 500288ISIN CODE : INE083A01026Industry : Pharmaceuticals & DrugsHouse : Morepen
BSE41.530.11 (+0.27 %)
PREV CLOSE (Rs.) 41.42
OPEN PRICE (Rs.) 41.47
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 94555
TODAY'S LOW / HIGH (Rs.)41.10 41.82
52 WK LOW / HIGH (Rs.)40.01 89.2
NSE41.510.05 (+0.12 %)
PREV CLOSE( Rs. ) 41.46
OPEN PRICE (Rs.) 41.60
BID PRICE (QTY) 41.51 (1627)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 837935
TODAY'S LOW / HIGH(Rs.) 41.05 41.91
52 WK LOW / HIGH (Rs.)40.01 88.7

Financial Ratios

Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)2.151.880.762.132.16
   CEPS(Rs)2.682.551.302.712.83
   DPS(Rs)0.200.000.000.000.00
   Book NAV/Share(Rs)21.1016.5814.7311.568.47
   Tax Rate(%)23.9128.6530.6319.751.44
Margin Ratios
   Core EBITDA Margin(%)9.619.385.618.849.98
   EBIT Margin(%)9.028.234.078.358.44
   Pre Tax Margin(%)8.568.013.938.198.29
   PAT Margin (%)6.515.722.736.578.17
   Cash Profit Margin (%)8.117.704.708.3610.72
Performance Ratios
   ROA(%)7.698.043.5510.5512.76
   ROE(%)11.7812.085.9321.7929.20
   ROCE(%)15.4816.828.4024.8627.13
   Asset Turnover(x)1.181.411.301.601.56
   Sales/Fixed Asset(x)2.502.652.232.491.72
   Working Capital/Sales(x)2.753.473.265.579.66
Efficiency Ratios
   Fixed Capital/Sales(x)0.400.380.450.400.58
   Receivable days65.4563.5066.1651.0449.10
   Inventory Days55.2651.5564.9853.2348.20
   Payable days107.9493.6798.3286.9394.60
Valuation Parameters
   PER(x)22.2122.3633.9417.2014.89
   PCE(x)17.8416.5319.7113.5211.35
   Price/Book(x)2.272.541.743.173.80
   Yield(%)0.420.000.000.000.00
   EV/Net Sales(x)1.461.260.901.111.17
   EV/Core EBITDA(x)13.7812.3214.9610.9810.68
   EV/EBIT(x)16.2215.2922.2013.3313.91
   EV/CE(x)2.152.431.651.611.63
   M Cap / Sales1.451.270.931.131.22
Growth Ratio
   Net Sales Growth(%)7.1719.25-8.3630.2039.27
   Core EBITDA Growth(%)11.49101.47-45.3620.0567.42
   EBIT Growth(%)17.49140.97-55.2928.74144.09
   PAT Growth(%)22.14149.82-61.964.73189.14
   EPS Growth(%)14.50148.62-64.44-1.40189.15
Financial Stability Ratios
   Total Debt/Equity(x)0.070.030.030.030.04
   Current Ratio(x)2.322.212.351.611.30
   Quick Ratio(x)1.721.591.641.000.87
   Interest Cover(x)19.5937.5029.1553.2256.09
   Total Debt/Mcap(x)0.030.010.020.010.01